Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada

Abstract

Despite widespread use of fluoroquinolones for treatment of common bacterial infections, resistance among clinical isolates of M. tuberculosis in the United States and Canada remains rare, occurring primarily among multidrug-resistant strains.